The authors recommend that dysplasia of any grade detected on BE biopsies be confirmed by a second pathologist who has expertise in gastrointestinal pathology.
Investigators compared the efficacy and adverse events of combining paclitaxel with either fluorouracil, cisplatin, or carboplatin in patients with esophageal squamous cell carcinoma.
The application is supported by data from the pivotal phase 3 PHALCON-EE trial which compared the efficacy and safety of vonoprazan to lansoprazole in patients with erosive esophagitis.
Investigators assessed the efficacy of water jelly ingestion for rehabilitation and aspiration prevention in older patients with moderate to severe dysphagia.
Investigators assessed the safety and efficacy of nivolumab combination therapy vs chemotherapy alone for the treatment of advanced esophageal squamous-cell carcinoma.
Investigators assessed the safety and efficacy of amrelizumab combined with apatinib as a second-line treatment for patients with advanced esophageal squamous cell carcinoma.
Investigators assessed overall characteristics of postendoscopy upper gastrointestinal cancers and compared them with those of initially detected cancers.
Investigators assessed the frequency of endoscopic monitoring in children with eosinophilic esophagitis and its relationship with certain demographic factors.